Mammary Tumor Virus, Mouse
"Mammary Tumor Virus, Mouse" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The type species of BETARETROVIRUS commonly latent in mice. It causes mammary adenocarcinoma in a genetically susceptible strain of mice when the appropriate hormonal influences operate.
| Descriptor ID |
D008324
|
| MeSH Number(s) |
B04.613.807.124.500 B04.820.650.124.500
|
| Concept/Terms |
Mammary Tumor Virus, Mouse- Mammary Tumor Virus, Mouse
- Mammary Cancer Virus
- Mammary Tumor Viruses, Mouse
- Bittner Virus
- Mouse mammary tumor virus
|
Below are MeSH descriptors whose meaning is more general than "Mammary Tumor Virus, Mouse".
Below are MeSH descriptors whose meaning is more specific than "Mammary Tumor Virus, Mouse".
This graph shows the total number of publications written about "Mammary Tumor Virus, Mouse" by people in this website by year, and whether "Mammary Tumor Virus, Mouse" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 0 | 3 | 3 |
| 2010 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mammary Tumor Virus, Mouse" by people in Profiles.
-
Little JL, Serzhanova V, Izumchenko E, Egleston BL, Parise E, Klein-Szanto AJ, Loudon G, Shubina M, Seo S, Kurokawa M, Ochs MF, Golemis EA. A requirement for Nedd9 in luminal progenitor cells prior to mammary tumorigenesis in MMTV-HER2/ErbB2 mice. Oncogene. 2014 Jan 23; 33(4):411-20.
-
Singh MK, Izumchenko E, Klein-Szanto AJ, Egleston BL, Wolfson M, Golemis EA. Enhanced genetic instability and dasatinib sensitivity in mammary tumor cells lacking NEDD9. Cancer Res. 2010 Nov 01; 70(21):8907-16.
-
Thakur ML, Devadhas D, Zhang K, Pestell RG, Wang C, McCue P, Wickstrom E. Imaging spontaneous MMTVneu transgenic murine mammary tumors: targeting metabolic activity versus genetic products. J Nucl Med. 2010 Jan; 51(1):106-11.
-
Izumchenko E, Singh MK, Plotnikova OV, Tikhmyanova N, Little JL, Serebriiskii IG, Seo S, Kurokawa M, Egleston BL, Klein-Szanto A, Pugacheva EN, Hardy RR, Wolfson M, Connolly DC, Golemis EA. NEDD9 promotes oncogenic signaling in mammary tumor development. Cancer Res. 2009 Sep 15; 69(18):7198-206.
-
Tomblyn S, Springs AE, Langenheim JF, Chen WY. Combination therapy using three novel prolactin receptor antagonist-based fusion proteins effectively inhibits tumor recurrence and metastasis in HER2/neu transgenic mice. Int J Oncol. 2009 Apr; 34(4):1139-46.
-
Siracusa LD, Jenkins NA, Copeland NG. Identification and applications of repetitive probes for gene mapping in the mouse. Genetics. 1991 Jan; 127(1):169-79.